Xin Lang Cai Jing·2025-11-07 07:13Core Viewpoint - Spring Medical has experienced a decline in stock price, with a cumulative drop of 7.83% over the past five days, closing at 26.62 yuan per share on November 7, 2023, with a total market capitalization of 10.211 billion yuan [1] Company Overview - Beijing Spring Medical Co., Ltd. was established on February 12, 1998, and went public on December 30, 2021. The company specializes in the research, production, and sales of implantable orthopedic medical devices [1] - The main products include joint prosthetics and spinal implant products, covering major human joints such as hip, knee, shoulder, and elbow, as well as a full range of spinal fixation systems [1] - The company's revenue composition is primarily from medical device products (99.89%), with a minor contribution from other sources (0.11%) [1] Fund Holdings - Rongtong Fund holds a significant position in Spring Medical, with its Rongtong Healthcare Industry Mixed A/B Fund (161616) owning 1,102,600 shares, representing 3.27% of the fund's net value, making it the tenth largest holding [2] - The fund has incurred a floating loss of approximately 716,700 yuan today and a total floating loss of 2,491,900 yuan during the five-day decline [2] Fund Manager Performance - The fund manager, Wan Minyuan, has a tenure of 9 years and 76 days, with a total fund size of 5.957 billion yuan, achieving a best return of 139.47% and a worst return of -21.98% during his tenure [3] - Co-manager Liu Xiyang has been in position for 1 year and 238 days, managing a fund size of 839 million yuan, with a best return of -3.58% and a worst return of -4.4% [3]